
EAU 2019

European Association of Urology annual congress
15-19 March 2019, Barcelona, Spain
CONTENTS
Online First
Prostate Cancer
Enzalutamide plus ADT Improves Outcomes for Metastatic Hormone-sensitive Prostate Cancer

Prostate Cancer Active Surveillance: Better Patient Risk Stratification and Use of Imaging
The Role of Pelvic Lymph Node Dissection in Prostate Cancer: Extended Vs Standard
When to Use Imaging and Imaging-guided Therapies

Radioguided Surgery Is the Future?
Bladder Cancer

Largest Safety Study of Its Kind with Atezolizumab in Metastatic Bladder Cancer

Bladder Cancer Risk and Early Detection

Consensus Treatment Pathway for Patients with Limited Pelvic Lymph Node Involvement in Otherwise Localised Bladder Cancer
FGFR3 Gene Mutation: Favourable Prognostic Impact in Bladder Cancer
Bladder Cancer in Young Patients
Spanish Study Directly Links Surgical Volume with Mortality in Bladder Cancer Patients Undergoing Cystectomy

Updated Interim Results of Phase 2 Trial of Pembrolizumab for High-risk NMIBC Unresponsive to BCG

Robot-assisted Radical Cystectomy or Open Radical Cystectomy?
Renal Transplantation and Renal Cell Carcinoma

Renal Cell Carcinoma
Andrology

HPV and Penile Cancer

Male Infertility/Premature Ejaculation
